» Articles » PMID: 35907914

Epstein-Barr Virus-encoded MicroRNA BART22 Serves As Novel Biomarkers and Drives Malignant Transformation of Nasopharyngeal Carcinoma

Overview
Journal Cell Death Dis
Date 2022 Jul 30
PMID 35907914
Authors
Affiliations
Soon will be listed here.
Abstract

Nasopharyngeal carcinoma (NPC) is an epithelial malignancy ubiquitously associated with Epstein-Barr virus (EBV). EBV generates various viral microRNAs (miRNAs) by processing the BHRF1 and BamHI A rightward (BART) transcripts. These BART miRNAs are abundantly expressed in NPC, but their functions and molecular mechanisms remain largely unknown. Our study found that the EBV-encoded microRNA BART-22 was significantly upregulated in NPC tissues and positively correlated with tumor progression. Furthermore, we found that EBV-miR-BART-22 was a significant predictor of poor prognosis in NPC. A reliable nomogram model to predict the preoperative overall survival (OS) of NPC patients was established. The area under the receiver operating characteristic (ROC) curve value for 5-year survival was 0.91. Elevated levels of EBV-miR-BART-22 significantly promoted the epithelial-mesenchymal transition (EMT) and metastasis of NPC cells in vivo and in vitro. We found that EBV-miR-BART-22 directly targets the 3'-UTR of MOSPD2 mRNA to promote the EMT and metastasis of NPC cells by activating the Wnt/β-catenin signaling pathway. Our findings provide a potential prognostic biomarker and new insight into the molecular mechanisms of NPC metastasis.

Citing Articles

The 'Oma's of the Gammas-Cancerogenesis by γ-Herpesviruses.

Banerjee A, Dass D, Mukherjee S, Kaul M, Harshithkumar R, Bagchi P Viruses. 2025; 16(12.

PMID: 39772235 PMC: 11680331. DOI: 10.3390/v16121928.


Global trends in research of nasopharyngeal carcinoma: a bibliometric and visualization analysis.

An G, Liu J, Lin T, He L, He Y Front Oncol. 2024; 14:1392245.

PMID: 39015496 PMC: 11249725. DOI: 10.3389/fonc.2024.1392245.


Fuyuan decoction prevents nasopharyngeal carcinoma metastasis by inhibiting circulating tumor cells/ endothelial cells interplay and enhancing anti-cancer immune response.

Ye Y, Lin M, Zhou G, Wang W, Yao Y, Su Y Front Pharmacol. 2024; 15:1355650.

PMID: 38738179 PMC: 11084272. DOI: 10.3389/fphar.2024.1355650.


Novel plasma microRNA expression features in diagnostic use for Epstein-Barr virus-associated febrile diseases.

Xu Y, Chen Y, Yang Q, Lu Y, Zhou R, Liu H Heliyon. 2024; 10(5):e26810.

PMID: 38444478 PMC: 10912469. DOI: 10.1016/j.heliyon.2024.e26810.


Crosstalk between Non-Coding RNAs and Wnt/β-Catenin Signaling in Head and Neck Cancer: Identification of Novel Biomarkers and Therapeutic Agents.

Sajeev A, BharathwajChetty B, Vishwa R, AlQahtani M, Abbas M, Sethi G Noncoding RNA. 2023; 9(5).

PMID: 37888209 PMC: 10610319. DOI: 10.3390/ncrna9050063.


References
1.
Li Y, Hu C, Shao Q, Huang M, Hou J, Xie D . Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. J Transl Med. 2008; 6:1. PMC: 2254380. DOI: 10.1186/1479-5876-6-1. View

2.
Kuzembayeva M, Hayes M, Sugden B . Multiple functions are mediated by the miRNAs of Epstein-Barr virus. Curr Opin Virol. 2014; 7:61-5. PMC: 4149930. DOI: 10.1016/j.coviro.2014.04.003. View

3.
Epstein M, ACHONG B, BARR Y . VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Lancet. 1964; 1(7335):702-3. DOI: 10.1016/s0140-6736(64)91524-7. View

4.
Thiery J, Sleeman J . Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006; 7(2):131-42. DOI: 10.1038/nrm1835. View

5.
Zou Y, Yang R, Huang M, Kong Y, Sheng J, Tao Z . NOTCH2 negatively regulates metastasis and epithelial-Mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2019; 38(1):456. PMC: 6836530. DOI: 10.1186/s13046-019-1463-x. View